Fox Run Management, L.L.C. Innoviva, Inc. Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 17, 2019	BUY	$13.1 - $14.95 $141,925 - $161,968	10,834 New	10,834 $158,000
Q3 2018 Oct 05, 2018	SELL	$13.63 - $15.7 $300,964 - $346,671	-22,081 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$13.44 - $17.59 $544,992 - $713,274	-40,550 Reduced 64.74%	22,081 $305,000
Q1 2018 Apr 17, 2018	BUY	$13.8 - $16.99 $864,307 - $1.06 Million	62,631 New	62,631 $1.04 Million

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.32B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.